FDA approves new version of Prevnar

The approval was a champagne-toast moment for New York-based Pfizer Inc., which last year acquired Prevnar's developer Wyeth. Prevnar earned $2.7 billion for Wyeth in 2008, and it will continue to be marketed out of the Collegeville facility that served...